Trexquant Investment LP Sells 3,839 Shares of iRadimed Corporation $IRMD

Trexquant Investment LP cut its stake in iRadimed Corporation (NASDAQ:IRMD - Free Report) by 32.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,036 shares of the medical equipment provider's stock after selling 3,839 shares during the quarter. Trexquant Investment LP owned about 0.06% of iRadimed worth $422,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the company. First Horizon Advisors Inc. raised its position in shares of iRadimed by 78.7% during the first quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock valued at $27,000 after buying an additional 226 shares during the last quarter. US Bancorp DE raised its holdings in shares of iRadimed by 132.7% in the 1st quarter. US Bancorp DE now owns 1,436 shares of the medical equipment provider's stock valued at $75,000 after purchasing an additional 819 shares during the period. Quantbot Technologies LP bought a new stake in iRadimed in the 1st quarter valued at about $78,000. Comerica Bank lifted its stake in iRadimed by 21.4% in the 1st quarter. Comerica Bank now owns 2,288 shares of the medical equipment provider's stock valued at $120,000 after purchasing an additional 404 shares during the last quarter. Finally, State of Wyoming acquired a new stake in shares of iRadimed during the fourth quarter worth $149,000. 92.34% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at iRadimed

In other iRadimed news, Director Monty K. Allen sold 1,102 shares of the business's stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $69.10, for a total value of $76,148.20. Following the transaction, the director directly owned 19,898 shares in the company, valued at $1,374,951.80. The trade was a 5.25% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 36.80% of the stock is owned by company insiders.

iRadimed Stock Performance

NASDAQ:IRMD traded down $3.00 during midday trading on Friday, reaching $71.27. 39,307 shares of the stock traded hands, compared to its average volume of 39,449. The company has a fifty day moving average of $66.07 and a 200 day moving average of $58.48. The stock has a market capitalization of $906.55 million, a P/E ratio of 43.99 and a beta of 1.02. iRadimed Corporation has a 12 month low of $46.86 and a 12 month high of $74.43.

iRadimed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Monday, August 18th were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Monday, August 18th. iRadimed's payout ratio is presently 41.98%.

iRadimed Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.